OPT•benzinga•March 20, 2025 at 06:16 AM

Reported Earlier, Paratek Pharmaceuticals To Acquire Optinose In Deal Worth Up To $330M, Including $9 Cash And $5 In Milestone Cvrs Per Share

No summary available.

Read the full article from the original source for complete details and context.

Article published on March 20, 2025 by benzinga